By Duncan Graham-Rowe of Nature magazine The first drug to show signs of not just halting multiple sclerosis (MS), but actually reversing the nerve damage caused by the condition, has taken a significant step towards clinical approval.
Read More »By Duncan Graham-Rowe of Nature magazine The first drug to show signs of not just halting multiple sclerosis (MS), but actually reversing the nerve damage caused by the condition, has taken a significant step towards clinical approval.
Read More »